Member Database

Arul Chinnaiyan

Director, Michigan Center for Translational Pathology;
S.P. Hicks Endowed Professor of Pathology;
Investigator, Howard Hughes Medical Institute;
American Cancer Society Research Professor
Pathology/Urology
Medicine

Dr. Chinnaiyan’s laboratory is focused on using functional genomic, proteomic, metabolomic, and bioinformatics approaches to dissect and understand cancer biology as well as discover biomarkers. He and his collaborators have characterized a number of biomarkers of prostate cancer, including AMACR, EZH2, hespin, and sarcosine. His laboratory identified recurrent gene fusions of TMPRSS2 to ETS family transcription factors in prostate cancer, potentially redefining the molecular basis of prostate cancer as well as other common epithelial cancers. His laboratory developed the popular cancer profiling bioinformatics resource called Oncomine.

University Affiliation(s)

Rogel Cancer Center

Research Area(s)

Bioinformatics | Breast cancer | Genetics / Genomics / other OMICS | Prostate cancer

Grants

  • Co-investigator of: BIOLOGICAL DIFFERENCES BETWEEN PROSTATE CANCER CELLS THAT METASTASIZE TO BONE VERSUS SOFT TISSUE SITES
  • Principal investigator of: The Role of Polycomb Group Proteins in Prostate Cancer
  • Principal investigator of: MOLLECULAR CLASSIFICATION OF PROSTATE CANCER